Anixa Biosciences
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3150 Almaden Expy Ste 250, San Jose, Cal...Phone Number
(408) 708-9808Website
www.anixa.comRevenue
<$5 MillionStock Symbol
ANIXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Anixa Biosciences
Anixa Biosciences is a clinical stage biotechnology company focused on the treatment and prevention of cancer.Explore more
Anixa Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Anixa Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Anixa Biosciences has new funding data
Click to see if Anixa Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Anixa Biosciences
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Anixa Biosciences recently announced quarterly report
Check out if Anixa Biosciences is spiking on competitors!
Anixa Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Anixa Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Anixa Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Anixa Biosciences
Find 2 more new buyers
Compare Similar Companies to Anixa Biosciences
Compare insights from companies similar to Anixa Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Anixa Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Anixa Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Anixa Biosciences.
Anixa Biosciences Tech Stack
A closer look at the technologies used by Anixa Biosciences
See more technologies
Most Recent Scoops
Person-Based
Events, Medical Research, Pharmaceuticals
Person-Based
Events
Person-Based
Intellectual Property, Legal Affairs, Medical Research
Person-Based
Partnership, Business Development
Partnership
Partnership, Research & Development, Medical Research, Pharmaceuticals
Anixa Biosciences News & Media
Anixa Biosciences Interview Highlighting Breast Cancer Vaccine to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
SAN JOSE, Calif., Sept. 9, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that an interview of Chairman and CEO, Dr. Amit Kumar, and breast cancer vaccine...Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
Presentation to highlight Anixa's clinical progress and collaborations with leading cancer research institutions — Cleveland Clinic and Moffitt Cancer Center SAN JOSE, Calif., Sept. 3, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology...Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
Breast cancer vaccine final Phase 1 data shows all primary endpoints were met and protocol-defined immune responses in 74% of participants—Phase 2 preparations ongoing Ovarian cancer CAR-T therapy, lira-cel, advances to highest dose level to date in fifth cohort with lymphodepletion—four...Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Ovarian cancer CAR-T therapy, lira-cel, advances to highest dose level to date in fifth cohort with lymphodepletion—four patients surpass one year of survival, longest at approximately 28 months Breast cancer vaccine final Phase 1 data shows all primary endpoints were met and...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Anixa Biosciences
Sign Up For FreeTo access detailed company insights
Anixa Biosciences is a clinical stage biotechnology company focused on the treatment and prevention of cancer.... Read More
